

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 9.87788219 |
| 2 | retina homeostasis (GO:0001895) | 8.93603974 |
| 3 | humoral immune response (GO:0006959) | 8.17376529 |
| 4 | positive regulation of respiratory burst (GO:0060267) | 6.77035400 |
| 5 | negative regulation of B cell proliferation (GO:0030889) | 6.24981556 |
| 6 | positive regulation of B cell differentiation (GO:0045579) | 6.23167907 |
| 7 | regulation of respiratory burst (GO:0060263) | 5.98659681 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.94357379 |
| 9 | B cell receptor signaling pathway (GO:0050853) | 5.91243600 |
| 10 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 5.82069834 |
| 11 | negative regulation of glucose import (GO:0046325) | 5.66701939 |
| 12 | glomerular filtration (GO:0003094) | 5.63026812 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.53694723 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.53694723 |
| 15 | regulation of B cell differentiation (GO:0045577) | 5.24927479 |
| 16 | renal filtration (GO:0097205) | 4.99194196 |
| 17 | signal peptide processing (GO:0006465) | 4.97552121 |
| 18 | L-fucose metabolic process (GO:0042354) | 4.95670408 |
| 19 | L-fucose catabolic process (GO:0042355) | 4.95670408 |
| 20 | fucose catabolic process (GO:0019317) | 4.95670408 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.92589129 |
| 22 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.86010440 |
| 23 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.81797905 |
| 24 | aggressive behavior (GO:0002118) | 4.72230378 |
| 25 | negative regulation of glucose transport (GO:0010829) | 4.64697295 |
| 26 | positive regulation of Rho protein signal transduction (GO:0035025) | 4.63136300 |
| 27 | regulation of B cell proliferation (GO:0030888) | 4.55941681 |
| 28 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.52290810 |
| 29 | Peyers patch development (GO:0048541) | 4.52290810 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.47701114 |
| 31 | cellular response to zinc ion (GO:0071294) | 4.46346267 |
| 32 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.36517509 |
| 33 | hyperosmotic salinity response (GO:0042538) | 4.34963022 |
| 34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.34582147 |
| 35 | regulation of female receptivity (GO:0045924) | 4.25286116 |
| 36 | Fc receptor signaling pathway (GO:0038093) | 4.20986638 |
| 37 | Fc-epsilon receptor signaling pathway (GO:0038095) | 4.17242995 |
| 38 | female mating behavior (GO:0060180) | 4.15473516 |
| 39 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.14131148 |
| 40 | negative regulation of B cell apoptotic process (GO:0002903) | 4.13252964 |
| 41 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.08895647 |
| 42 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.95959049 |
| 43 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.92690904 |
| 44 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.88916827 |
| 45 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.85163778 |
| 46 | B cell mediated immunity (GO:0019724) | 3.84710110 |
| 47 | immune response-activating signal transduction (GO:0002757) | 3.83930339 |
| 48 | definitive hemopoiesis (GO:0060216) | 3.81791684 |
| 49 | response to interferon-beta (GO:0035456) | 3.72998128 |
| 50 | seminiferous tubule development (GO:0072520) | 3.71612061 |
| 51 | regulation of antigen processing and presentation (GO:0002577) | 3.55554451 |
| 52 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.52406322 |
| 53 | positive regulation of antigen processing and presentation (GO:0002579) | 3.51118080 |
| 54 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.50550691 |
| 55 | antibacterial humoral response (GO:0019731) | 3.50247239 |
| 56 | positive regulation of Rap GTPase activity (GO:0032854) | 3.49032523 |
| 57 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.47188481 |
| 58 | activation of immune response (GO:0002253) | 3.46241758 |
| 59 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.45442276 |
| 60 | peptidyl-asparagine modification (GO:0018196) | 3.43695261 |
| 61 | detection of bacterium (GO:0016045) | 3.40541363 |
| 62 | positive regulation of immunoglobulin production (GO:0002639) | 3.39417812 |
| 63 | mannose metabolic process (GO:0006013) | 3.39233144 |
| 64 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.35089962 |
| 65 | antimicrobial humoral response (GO:0019730) | 3.33172189 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.32670986 |
| 67 | endothelium development (GO:0003158) | 3.30729763 |
| 68 | positive regulation of nuclease activity (GO:0032075) | 3.29223711 |
| 69 | maternal placenta development (GO:0001893) | 3.28105241 |
| 70 | histamine secretion (GO:0001821) | 3.27630162 |
| 71 | pinocytosis (GO:0006907) | 3.26942037 |
| 72 | detection of other organism (GO:0098543) | 3.25505385 |
| 73 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.24170711 |
| 74 | N-acetylneuraminate metabolic process (GO:0006054) | 3.22380571 |
| 75 | regulation of B cell activation (GO:0050864) | 3.20144128 |
| 76 | protein N-linked glycosylation (GO:0006487) | 3.19539096 |
| 77 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.18497518 |
| 78 | B cell proliferation (GO:0042100) | 3.17369905 |
| 79 | negative regulation of osteoclast differentiation (GO:0045671) | 3.15317928 |
| 80 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.15301754 |
| 81 | negative regulation of B cell activation (GO:0050869) | 3.14671823 |
| 82 | cellular response to interferon-beta (GO:0035458) | 3.14307685 |
| 83 | regulation of nuclease activity (GO:0032069) | 3.13070569 |
| 84 | negative thymic T cell selection (GO:0045060) | 3.12504010 |
| 85 | positive regulation of type 2 immune response (GO:0002830) | 3.10136924 |
| 86 | regulation of transmission of nerve impulse (GO:0051969) | 3.09826481 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.09640911 |
| 88 | intestinal epithelial cell development (GO:0060576) | 3.09295403 |
| 89 | mature B cell differentiation (GO:0002335) | 3.08034641 |
| 90 | bone resorption (GO:0045453) | 3.07685423 |
| 91 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.07372262 |
| 92 | cellular response to unfolded protein (GO:0034620) | 3.06388467 |
| 93 | Golgi transport vesicle coating (GO:0048200) | 3.05635171 |
| 94 | COPI coating of Golgi vesicle (GO:0048205) | 3.05635171 |
| 95 | cellular response to exogenous dsRNA (GO:0071360) | 3.05029317 |
| 96 | cellular response to type I interferon (GO:0071357) | 3.03421526 |
| 97 | type I interferon signaling pathway (GO:0060337) | 3.03421526 |
| 98 | maternal behavior (GO:0042711) | 3.01505659 |
| 99 | response to type I interferon (GO:0034340) | 3.00988927 |
| 100 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.00842070 |
| 101 | purine nucleotide salvage (GO:0032261) | 3.00559567 |
| 102 | complement activation, classical pathway (GO:0006958) | 22.1691313 |
| 103 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98676977 |
| 104 | serine transport (GO:0032329) | 2.98494669 |
| 105 | protein kinase C signaling (GO:0070528) | 2.96392110 |
| 106 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.96248259 |
| 107 | neutrophil activation involved in immune response (GO:0002283) | 2.95610240 |
| 108 | regulation of Rap GTPase activity (GO:0032317) | 2.94915270 |
| 109 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.94871436 |
| 110 | phenylpropanoid metabolic process (GO:0009698) | 2.91719441 |
| 111 | N-glycan processing (GO:0006491) | 2.91498101 |
| 112 | regulation of gamma-delta T cell activation (GO:0046643) | 2.90651733 |
| 113 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.87849233 |
| 114 | positive regulation of prostaglandin secretion (GO:0032308) | 2.84580630 |
| 115 | B cell homeostasis (GO:0001782) | 2.84572347 |
| 116 | L-serine transport (GO:0015825) | 2.84081646 |
| 117 | negative T cell selection (GO:0043383) | 2.83592382 |
| 118 | regulation of cellular extravasation (GO:0002691) | 2.82691904 |
| 119 | mitochondrial calcium ion transport (GO:0006851) | 2.82561973 |
| 120 | cellular hyperosmotic response (GO:0071474) | 2.80490288 |
| 121 | ER-nucleus signaling pathway (GO:0006984) | 2.80377519 |
| 122 | hyperosmotic response (GO:0006972) | 2.78429601 |
| 123 | response to host immune response (GO:0052572) | 2.78043723 |
| 124 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.78043723 |
| 125 | regulation of necrotic cell death (GO:0010939) | 2.77714385 |
| 126 | cellular response to topologically incorrect protein (GO:0035967) | 2.77466170 |
| 127 | positive regulation of neutrophil migration (GO:1902624) | 2.76109826 |
| 128 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.76109826 |
| 129 | regulation of superoxide anion generation (GO:0032928) | 2.76003115 |
| 130 | deoxyribonucleotide catabolic process (GO:0009264) | 2.74825417 |
| 131 | defense response to protozoan (GO:0042832) | 2.74236904 |
| 132 | respiratory burst (GO:0045730) | 2.72023266 |
| 133 | sialylation (GO:0097503) | 2.70539490 |
| 134 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.70158751 |
| 135 | negative regulation of cell killing (GO:0031342) | 2.70158751 |
| 136 | defense response to Gram-negative bacterium (GO:0050829) | 2.68694054 |
| 137 | thymic T cell selection (GO:0045061) | 2.67892764 |
| 138 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.67772458 |
| 139 | autophagic vacuole fusion (GO:0000046) | 2.67741008 |
| 140 | positive regulation of B cell activation (GO:0050871) | 2.67340652 |
| 141 | regulation of mast cell degranulation (GO:0043304) | 2.66777268 |
| 142 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.64380108 |
| 143 | parental behavior (GO:0060746) | 2.63914124 |
| 144 | response to endoplasmic reticulum stress (GO:0034976) | 2.63859904 |
| 145 | negative regulation of innate immune response (GO:0045824) | 2.63841892 |
| 146 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.63600151 |
| 147 | negative regulation of bone resorption (GO:0045779) | 2.61166492 |
| 148 | deoxyribose phosphate catabolic process (GO:0046386) | 2.59751219 |
| 149 | tissue homeostasis (GO:0001894) | 2.59722170 |
| 150 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.59304079 |
| 151 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.59063599 |
| 152 | response to host (GO:0075136) | 2.59063599 |
| 153 | response to host defenses (GO:0052200) | 2.59063599 |
| 154 | proline biosynthetic process (GO:0006561) | 2.58951932 |
| 155 | actin nucleation (GO:0045010) | 2.58945512 |
| 156 | positive regulation of histone deacetylation (GO:0031065) | 2.58757336 |
| 157 | positive thymic T cell selection (GO:0045059) | 2.55961307 |
| 158 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.55345161 |
| 159 | T cell selection (GO:0045058) | 2.55201210 |
| 160 | neutrophil activation (GO:0042119) | 2.51504727 |
| 161 | B cell activation (GO:0042113) | 2.49520630 |
| 162 | mature B cell differentiation involved in immune response (GO:0002313) | 2.48437338 |
| 163 | I-kappaB phosphorylation (GO:0007252) | 2.48350476 |
| 164 | regulation of B cell apoptotic process (GO:0002902) | 2.47537410 |
| 165 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.47271170 |
| 166 | complement activation (GO:0006956) | 16.9871985 |
| 167 | protein activation cascade (GO:0072376) | 10.9830585 |
| 168 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 10.0060676 |
| 169 | Fc-gamma receptor signaling pathway (GO:0038094) | 10.0060676 |
| 170 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 10.0060676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.09926887 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.57951732 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.23308243 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.17861770 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.65394640 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 4.23490610 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.08025232 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.91085433 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.82537896 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.74823159 |
| 11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.61146151 |
| 12 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.48284169 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28078734 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.13768117 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.97808884 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.97530945 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.94682511 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.89936853 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.69025163 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.52093913 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.44951209 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43643691 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.42866854 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.20554033 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19909144 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.15989769 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12787442 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 2.05050834 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04973627 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.04760669 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04105343 |
| 32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.02952958 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02383869 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.01559599 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 2.01249240 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.91602849 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91405828 |
| 38 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.86726836 |
| 39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81620309 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.76799942 |
| 41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.74528683 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73483635 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.72368295 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.69780173 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.69130565 |
| 46 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.68689453 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.67383722 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64276671 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61330868 |
| 50 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.58277645 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.57216218 |
| 52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53167675 |
| 53 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49689545 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47860721 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.46651854 |
| 56 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.44155746 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44142412 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43866624 |
| 59 | MAF_26560356_Chip-Seq_TH2_Human | 1.38737392 |
| 60 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.38702901 |
| 61 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.35663272 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35013046 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34690038 |
| 64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.33141031 |
| 65 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.33137300 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31130860 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29105781 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24671513 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22775356 |
| 70 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.22284224 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21207909 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.20332333 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19677501 |
| 74 | P300_27268052_Chip-Seq_Bcells_Human | 1.18651501 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16110343 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16042402 |
| 77 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15842297 |
| 78 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14538478 |
| 79 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12150237 |
| 80 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09058278 |
| 81 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07976316 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06587376 |
| 83 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.06127663 |
| 84 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06080193 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05154013 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04958262 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04263360 |
| 88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03809965 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03593282 |
| 90 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.02757000 |
| 91 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02156394 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00748193 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00463674 |
| 94 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99863710 |
| 95 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.99364178 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97920871 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97904570 |
| 98 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97876011 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97548902 |
| 100 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97459529 |
| 101 | P68_20966046_ChIP-Seq_HELA_Human | 0.95526351 |
| 102 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94068465 |
| 103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93745772 |
| 104 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.91031567 |
| 105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89758087 |
| 106 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88980874 |
| 107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88847861 |
| 108 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88470803 |
| 109 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.87849131 |
| 110 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.87590063 |
| 111 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87335124 |
| 112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86879958 |
| 113 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.86331395 |
| 114 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.85729441 |
| 115 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84928229 |
| 116 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83832892 |
| 117 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83696244 |
| 118 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.83381114 |
| 119 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.83261210 |
| 120 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83126339 |
| 121 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82970962 |
| 122 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80052525 |
| 123 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76421638 |
| 124 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.76376633 |
| 125 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75887798 |
| 126 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75204996 |
| 127 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.74338333 |
| 128 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.74139184 |
| 129 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73856362 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72626660 |
| 131 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72171322 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.72058739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.42140440 |
| 2 | MP0001800_abnormal_humoral_immune | 4.82787724 |
| 3 | MP0003303_peritoneal_inflammation | 4.67557194 |
| 4 | MP0003724_increased_susceptibility_to | 3.95986690 |
| 5 | MP0005387_immune_system_phenotype | 3.68617599 |
| 6 | MP0001790_abnormal_immune_system | 3.68617599 |
| 7 | MP0002452_abnormal_antigen_presenting | 3.55771906 |
| 8 | MP0005671_abnormal_response_to | 3.20946740 |
| 9 | MP0002723_abnormal_immune_serum | 2.98400171 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.87514150 |
| 11 | MP0001819_abnormal_immune_cell | 2.82455831 |
| 12 | MP0002398_abnormal_bone_marrow | 2.79552524 |
| 13 | MP0000685_abnormal_immune_system | 2.72981896 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.72240083 |
| 15 | MP0000716_abnormal_immune_system | 2.68842510 |
| 16 | MP0001879_abnormal_lymphatic_vessel | 2.45130579 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.44254584 |
| 18 | MP0006054_spinal_hemorrhage | 2.43302823 |
| 19 | MP0000689_abnormal_spleen_morphology | 2.39377081 |
| 20 | MP0005645_abnormal_hypothalamus_physiol | 2.35561239 |
| 21 | MP0005025_abnormal_response_to | 2.21874476 |
| 22 | MP0002429_abnormal_blood_cell | 2.20553494 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.18306013 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.17449950 |
| 25 | MP0004264_abnormal_extraembryonic_tissu | 2.14254999 |
| 26 | MP0003436_decreased_susceptibility_to | 2.12920418 |
| 27 | MP0002396_abnormal_hematopoietic_system | 2.02231506 |
| 28 | MP0002419_abnormal_innate_immunity | 1.99075272 |
| 29 | MP0010234_abnormal_vibrissa_follicle | 1.98126695 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.97850606 |
| 31 | MP0002722_abnormal_immune_system | 1.97538328 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.95913849 |
| 33 | MP0002006_tumorigenesis | 1.83967313 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.81342265 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.80805480 |
| 36 | MP0004947_skin_inflammation | 1.75389670 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.72613105 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.70321185 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.65536391 |
| 40 | MP0002132_abnormal_respiratory_system | 1.57339726 |
| 41 | MP0004782_abnormal_surfactant_physiolog | 1.51056766 |
| 42 | MP0002405_respiratory_system_inflammati | 1.50383009 |
| 43 | MP0005166_decreased_susceptibility_to | 1.44576202 |
| 44 | MP0009785_altered_susceptibility_to | 1.37705380 |
| 45 | MP0003045_fibrosis | 1.35731173 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.33726676 |
| 47 | MP0001873_stomach_inflammation | 1.27981085 |
| 48 | MP0008004_abnormal_stomach_pH | 1.27642369 |
| 49 | MP0005275_abnormal_skin_tensile | 1.27506384 |
| 50 | MP0000858_altered_metastatic_potential | 1.23658774 |
| 51 | MP0004808_abnormal_hematopoietic_stem | 1.19406080 |
| 52 | MP0002796_impaired_skin_barrier | 1.18224634 |
| 53 | MP0002019_abnormal_tumor_incidence | 1.17045055 |
| 54 | MP0002933_joint_inflammation | 1.15206682 |
| 55 | MP0005310_abnormal_salivary_gland | 1.15128631 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.15045641 |
| 57 | MP0006082_CNS_inflammation | 1.14273402 |
| 58 | MP0008057_abnormal_DNA_replication | 1.09338168 |
| 59 | MP0003866_abnormal_defecation | 1.08403202 |
| 60 | MP0010352_gastrointestinal_tract_polyps | 1.07847296 |
| 61 | MP0009840_abnormal_foam_cell | 1.06876113 |
| 62 | MP0001664_abnormal_digestion | 1.04834949 |
| 63 | MP0000681_abnormal_thyroid_gland | 1.04444547 |
| 64 | MP0009697_abnormal_copulation | 1.03180372 |
| 65 | MP0000920_abnormal_myelination | 1.02488241 |
| 66 | MP0005076_abnormal_cell_differentiation | 1.00631041 |
| 67 | MP0008569_lethality_at_weaning | 1.00011383 |
| 68 | MP0000490_abnormal_crypts_of | 0.99229475 |
| 69 | MP0002136_abnormal_kidney_physiology | 0.98237295 |
| 70 | MP0008872_abnormal_physiological_respon | 0.98198345 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 0.96871965 |
| 72 | MP0004510_myositis | 0.96013885 |
| 73 | MP0001853_heart_inflammation | 0.95667709 |
| 74 | MP0009764_decreased_sensitivity_to | 0.93920963 |
| 75 | MP0000343_altered_response_to | 0.93393967 |
| 76 | MP0008961_abnormal_basal_metabolism | 0.91748876 |
| 77 | MP0005360_urolithiasis | 0.90784948 |
| 78 | MP0005165_increased_susceptibility_to | 0.90438677 |
| 79 | MP0003448_altered_tumor_morphology | 0.89558404 |
| 80 | MP0009278_abnormal_bone_marrow | 0.86387394 |
| 81 | MP0002139_abnormal_hepatobiliary_system | 0.85347044 |
| 82 | MP0001663_abnormal_digestive_system | 0.84493324 |
| 83 | MP0008469_abnormal_protein_level | 0.84062140 |
| 84 | MP0004043_abnormal_pH_regulation | 0.83713454 |
| 85 | MP0001533_abnormal_skeleton_physiology | 0.83183527 |
| 86 | MP0005390_skeleton_phenotype | 0.82789546 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.82585332 |
| 88 | MP0005381_digestive/alimentary_phenotyp | 0.81665870 |
| 89 | MP0009379_abnormal_foot_pigmentation | 0.81351827 |
| 90 | MP0004147_increased_porphyrin_level | 0.81284579 |
| 91 | MP0000733_abnormal_muscle_development | 0.80452267 |
| 92 | MP0001919_abnormal_reproductive_system | 0.79508118 |
| 93 | MP0001851_eye_inflammation | 0.79457242 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.79207565 |
| 95 | MP0000003_abnormal_adipose_tissue | 0.77449742 |
| 96 | MP0005023_abnormal_wound_healing | 0.76346617 |
| 97 | MP0001545_abnormal_hematopoietic_system | 0.75910329 |
| 98 | MP0005397_hematopoietic_system_phenotyp | 0.75910329 |
| 99 | MP0000609_abnormal_liver_physiology | 0.74522605 |
| 100 | MP0005164_abnormal_response_to | 0.74374766 |
| 101 | MP0005058_abnormal_lysosome_morphology | 0.73684096 |
| 102 | MP0003690_abnormal_glial_cell | 0.72886072 |
| 103 | MP0002168_other_aberrant_phenotype | 0.72639296 |
| 104 | MP0000613_abnormal_salivary_gland | 0.72076695 |
| 105 | MP0009046_muscle_twitch | 0.71701117 |
| 106 | MP0009763_increased_sensitivity_to | 0.70515007 |
| 107 | MP0001765_abnormal_ion_homeostasis | 0.69498851 |
| 108 | MP0000249_abnormal_blood_vessel | 0.69036094 |
| 109 | MP0002998_abnormal_bone_remodeling | 0.68775112 |
| 110 | MP0002693_abnormal_pancreas_physiology | 0.68627685 |
| 111 | MP0005451_abnormal_body_composition | 0.67976119 |
| 112 | MP0006036_abnormal_mitochondrial_physio | 0.65511304 |
| 113 | MP0003252_abnormal_bile_duct | 0.65095224 |
| 114 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64963713 |
| 115 | MP0003075_altered_response_to | 0.64946315 |
| 116 | MP0002083_premature_death | 0.64732808 |
| 117 | MP0002133_abnormal_respiratory_system | 0.64432174 |
| 118 | MP0005388_respiratory_system_phenotype | 0.64432174 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.63764574 |
| 120 | MP0005319_abnormal_enzyme/_coenzyme | 0.63407766 |
| 121 | MP0002254_reproductive_system_inflammat | 0.61627322 |
| 122 | MP0003566_abnormal_cell_adhesion | 0.61060942 |
| 123 | MP0005075_abnormal_melanosome_morpholog | 0.60868432 |
| 124 | MP0008873_increased_physiological_sensi | 0.60509690 |
| 125 | MP0008874_decreased_physiological_sensi | 0.60142700 |
| 126 | MP0003795_abnormal_bone_structure | 0.59979670 |
| 127 | MP0009643_abnormal_urine_homeostasis | 0.59972198 |
| 128 | MP0001944_abnormal_pancreas_morphology | 0.59749093 |
| 129 | MP0002876_abnormal_thyroid_physiology | 0.59506760 |
| 130 | MP0001986_abnormal_taste_sensitivity | 0.59407653 |
| 131 | MP0000013_abnormal_adipose_tissue | 0.54986139 |
| 132 | MP0003186_abnormal_redox_activity | 0.54387166 |
| 133 | MP0000477_abnormal_intestine_morphology | 0.53695146 |
| 134 | MP0001191_abnormal_skin_condition | 0.52742304 |
| 135 | MP0001666_abnormal_nutrient_absorption | 0.52297478 |
| 136 | MP0001881_abnormal_mammary_gland | 0.51925732 |
| 137 | MP0002873_normal_phenotype | 0.50433636 |
| 138 | MP0002169_no_abnormal_phenotype | 0.50325702 |
| 139 | MP0000604_amyloidosis | 0.49544376 |
| 140 | MP0001958_emphysema | 0.49312982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.48617209 |
| 2 | B lymphocytopenia (HP:0010976) | 8.77383083 |
| 3 | Abnormality of B cell number (HP:0010975) | 8.77383083 |
| 4 | Colitis (HP:0002583) | 7.26596362 |
| 5 | Recurrent sinusitis (HP:0011108) | 6.87251249 |
| 6 | Cellulitis (HP:0100658) | 6.59408434 |
| 7 | Recurrent bronchitis (HP:0002837) | 6.27849965 |
| 8 | Papilloma (HP:0012740) | 6.15640240 |
| 9 | Verrucae (HP:0200043) | 6.15640240 |
| 10 | Recurrent viral infections (HP:0004429) | 5.82021878 |
| 11 | IgM deficiency (HP:0002850) | 5.53014555 |
| 12 | Prostate neoplasm (HP:0100787) | 5.48046892 |
| 13 | Inflammation of the large intestine (HP:0002037) | 5.40336594 |
| 14 | Gastrointestinal inflammation (HP:0004386) | 5.20869414 |
| 15 | Gastrointestinal stroma tumor (HP:0100723) | 5.07755856 |
| 16 | Meningitis (HP:0001287) | 4.89785741 |
| 17 | Recurrent pneumonia (HP:0006532) | 4.54835059 |
| 18 | Abnormality of the prostate (HP:0008775) | 4.51930439 |
| 19 | Chronic otitis media (HP:0000389) | 4.31606720 |
| 20 | Autoimmune hemolytic anemia (HP:0001890) | 3.96652860 |
| 21 | Osteomyelitis (HP:0002754) | 3.95413930 |
| 22 | Chronic sinusitis (HP:0011109) | 3.85592107 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.85380095 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.81848830 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 3.76566663 |
| 26 | Thyroiditis (HP:0100646) | 3.76293551 |
| 27 | Recurrent otitis media (HP:0000403) | 3.69817638 |
| 28 | Recurrent lower respiratory tract infections (HP:0002783) | 3.69085869 |
| 29 | Bronchitis (HP:0012387) | 3.52085383 |
| 30 | Sepsis (HP:0100806) | 3.45888890 |
| 31 | Emphysema (HP:0002097) | 3.37325746 |
| 32 | Stomatitis (HP:0010280) | 3.14591178 |
| 33 | IgG deficiency (HP:0004315) | 3.11321892 |
| 34 | Abnormality of T cell physiology (HP:0011840) | 3.08080929 |
| 35 | IgA deficiency (HP:0002720) | 3.04899177 |
| 36 | Skin rash (HP:0000988) | 3.01552449 |
| 37 | Recurrent fungal infections (HP:0002841) | 3.01334426 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.97884665 |
| 39 | Vasculitis (HP:0002633) | 2.86946664 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 2.86239634 |
| 41 | Orchitis (HP:0100796) | 2.85825262 |
| 42 | Restrictive lung disease (HP:0002091) | 2.79366641 |
| 43 | Abnormality of T cells (HP:0002843) | 2.75542675 |
| 44 | Lymphopenia (HP:0001888) | 2.72888655 |
| 45 | Recurrent abscess formation (HP:0002722) | 2.70448025 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.61478397 |
| 47 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.60953366 |
| 48 | Nasal polyposis (HP:0100582) | 2.59881089 |
| 49 | Recurrent bacterial skin infections (HP:0005406) | 2.55464659 |
| 50 | Abnormality of T cell number (HP:0011839) | 2.53749616 |
| 51 | Abnormality of male internal genitalia (HP:0000022) | 2.52779689 |
| 52 | T lymphocytopenia (HP:0005403) | 2.52694249 |
| 53 | Epistaxis (HP:0000421) | 2.52649657 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.52308304 |
| 55 | Hyperactive renin-angiotensin system (HP:0000841) | 2.47682875 |
| 56 | Small epiphyses (HP:0010585) | 2.46100949 |
| 57 | Erythema (HP:0010783) | 2.45647271 |
| 58 | Mitral stenosis (HP:0001718) | 2.41943359 |
| 59 | Recurrent skin infections (HP:0001581) | 2.32337845 |
| 60 | Acute lymphatic leukemia (HP:0006721) | 2.30108730 |
| 61 | Increased IgM level (HP:0003496) | 2.25374796 |
| 62 | Seborrheic dermatitis (HP:0001051) | 2.25095633 |
| 63 | Skin ulcer (HP:0200042) | 2.24955909 |
| 64 | Hypoplasia of the thymus (HP:0000778) | 2.23472500 |
| 65 | Abnormality of the nasal mucosa (HP:0000433) | 2.21110957 |
| 66 | Thoracic kyphosis (HP:0002942) | 2.20890430 |
| 67 | Gastrointestinal infarctions (HP:0005244) | 2.17482438 |
| 68 | Petechiae (HP:0000967) | 2.16689492 |
| 69 | Pili torti (HP:0003777) | 2.16138156 |
| 70 | Neutropenia (HP:0001875) | 2.15544758 |
| 71 | Bronchiectasis (HP:0002110) | 2.14159259 |
| 72 | Gingival bleeding (HP:0000225) | 2.07427780 |
| 73 | Retrobulbar optic neuritis (HP:0100654) | 2.07035444 |
| 74 | Optic neuritis (HP:0100653) | 2.07035444 |
| 75 | Gingivitis (HP:0000230) | 2.04595758 |
| 76 | Thrombocytosis (HP:0001894) | 2.04328552 |
| 77 | Premature loss of primary teeth (HP:0006323) | 2.04135629 |
| 78 | Chronic diarrhea (HP:0002028) | 2.03440162 |
| 79 | Hemoptysis (HP:0002105) | 2.02899103 |
| 80 | Microvesicular hepatic steatosis (HP:0001414) | 2.02232695 |
| 81 | Esophageal neoplasm (HP:0100751) | 2.01780026 |
| 82 | Neoplasm of head and neck (HP:0012288) | 2.01780026 |
| 83 | Cupped ribs (HP:0000887) | 2.01500592 |
| 84 | Increased IgE level (HP:0003212) | 2.01447315 |
| 85 | Ragged-red muscle fibers (HP:0003200) | 2.00829694 |
| 86 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.00813050 |
| 87 | Villous atrophy (HP:0011473) | 2.00813050 |
| 88 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.00804089 |
| 89 | Mediastinal lymphadenopathy (HP:0100721) | 2.00319607 |
| 90 | Abnormality of the pleura (HP:0002103) | 2.00165431 |
| 91 | Vacuolated lymphocytes (HP:0001922) | 1.99838870 |
| 92 | Purpura (HP:0000979) | 1.99543543 |
| 93 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99303213 |
| 94 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99303213 |
| 95 | Pulmonary infiltrates (HP:0002113) | 1.99009691 |
| 96 | Polygenic inheritance (HP:0010982) | 1.96797071 |
| 97 | Keratoconjunctivitis sicca (HP:0001097) | 1.96530971 |
| 98 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.94507674 |
| 99 | Eosinophilia (HP:0001880) | 1.94317281 |
| 100 | Abnormality of the peritoneum (HP:0002585) | 1.92984259 |
| 101 | Combined immunodeficiency (HP:0005387) | 1.92364060 |
| 102 | Viral hepatitis (HP:0006562) | 1.90865102 |
| 103 | Increased muscle lipid content (HP:0009058) | 1.90403947 |
| 104 | Hypermelanotic macule (HP:0001034) | 1.90390263 |
| 105 | Severe combined immunodeficiency (HP:0004430) | 1.84297527 |
| 106 | Eczematoid dermatitis (HP:0000976) | 1.79997805 |
| 107 | Myositis (HP:0100614) | 1.77663985 |
| 108 | Abnormal foot bone ossification (HP:0010675) | 1.77290928 |
| 109 | Autoimmune thrombocytopenia (HP:0001973) | 1.76261249 |
| 110 | Macroorchidism (HP:0000053) | 1.74352827 |
| 111 | Lymphoma (HP:0002665) | 1.74254862 |
| 112 | Chronic obstructive pulmonary disease (HP:0006510) | 1.73437968 |
| 113 | Obstructive lung disease (HP:0006536) | 1.73437968 |
| 114 | Abnormality of the fingertips (HP:0001211) | 1.70960414 |
| 115 | Arthralgia (HP:0002829) | 1.69932771 |
| 116 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.69840599 |
| 117 | Acrocyanosis (HP:0001063) | 1.69371420 |
| 118 | Mucosal telangiectasiae (HP:0100579) | 1.67958948 |
| 119 | Leukopenia (HP:0001882) | 1.67122634 |
| 120 | Papilledema (HP:0001085) | 1.66167490 |
| 121 | Pustule (HP:0200039) | 1.60082609 |
| 122 | Dehydration (HP:0001944) | 1.55929595 |
| 123 | Abnormality of eosinophils (HP:0001879) | 1.54218705 |
| 124 | Flattened epiphyses (HP:0003071) | 1.53648954 |
| 125 | Hypergammaglobulinemia (HP:0010702) | 1.48209790 |
| 126 | Teleangiectasia of the skin (HP:0100585) | 1.45882768 |
| 127 | Granulocytopenia (HP:0001913) | 1.43196199 |
| 128 | Periodontitis (HP:0000704) | 1.42542393 |
| 129 | Abnormality of the lumbar spine (HP:0100712) | 1.42369185 |
| 130 | Spondylolisthesis (HP:0003302) | 1.41191095 |
| 131 | Abnormality of the intrinsic pathway (HP:0010989) | 1.38075484 |
| 132 | Ulnar deviation of the wrist (HP:0003049) | 1.37383210 |
| 133 | Leukocytosis (HP:0001974) | 1.37283124 |
| 134 | Abnormal tarsal ossification (HP:0008369) | 1.35951882 |
| 135 | Xerostomia (HP:0000217) | 1.34730310 |
| 136 | Encephalitis (HP:0002383) | 1.33918436 |
| 137 | Dysostosis multiplex (HP:0000943) | 1.33558611 |
| 138 | Basal cell carcinoma (HP:0002671) | 1.33063865 |
| 139 | Hypertensive crisis (HP:0100735) | 1.30995008 |
| 140 | Chest pain (HP:0100749) | 1.30946318 |
| 141 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.30855692 |
| 142 | Urticaria (HP:0001025) | 1.30480012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.44518860 |
| 2 | MAP4K1 | 5.14178577 |
| 3 | TAOK3 | 3.19816786 |
| 4 | RIPK4 | 3.14101952 |
| 5 | GRK6 | 3.12596677 |
| 6 | MAP3K10 | 3.10652909 |
| 7 | TYK2 | 2.77619133 |
| 8 | FLT3 | 2.69950251 |
| 9 | SYK | 2.40184119 |
| 10 | MAP3K11 | 2.27965486 |
| 11 | SIK2 | 2.27230130 |
| 12 | VRK2 | 2.25289323 |
| 13 | TESK2 | 2.20406973 |
| 14 | CSF1R | 2.18953048 |
| 15 | SCYL2 | 2.17703240 |
| 16 | BLK | 2.01724848 |
| 17 | KIT | 1.99872677 |
| 18 | MAP4K2 | 1.93484440 |
| 19 | EIF2AK3 | 1.85601299 |
| 20 | MAP3K14 | 1.81612937 |
| 21 | BTK | 1.80415933 |
| 22 | KDR | 1.77343983 |
| 23 | JAK1 | 1.74638400 |
| 24 | NME2 | 1.69101059 |
| 25 | MAP3K13 | 1.64204714 |
| 26 | BMPR2 | 1.62067624 |
| 27 | TXK | 1.59575702 |
| 28 | IRAK3 | 1.50890996 |
| 29 | TNK2 | 1.49343679 |
| 30 | ITK | 1.48434682 |
| 31 | PRPF4B | 1.46286486 |
| 32 | STK10 | 1.40090089 |
| 33 | FGFR3 | 1.37143147 |
| 34 | LYN | 1.32713910 |
| 35 | HIPK2 | 1.32010074 |
| 36 | IRAK4 | 1.31559841 |
| 37 | MAP2K3 | 1.29344463 |
| 38 | HCK | 1.28139341 |
| 39 | TBK1 | 1.26914012 |
| 40 | MAP3K1 | 1.22713090 |
| 41 | PRKCH | 1.21691441 |
| 42 | PIK3CG | 1.20016895 |
| 43 | EEF2K | 1.19721389 |
| 44 | PIM1 | 1.17172168 |
| 45 | IKBKE | 1.16203588 |
| 46 | JAK3 | 1.15818924 |
| 47 | TAOK2 | 1.14825882 |
| 48 | IKBKB | 1.14197293 |
| 49 | FES | 1.12858244 |
| 50 | ARAF | 1.12717448 |
| 51 | LRRK2 | 1.11985620 |
| 52 | FGFR4 | 1.08527179 |
| 53 | NEK2 | 1.03728434 |
| 54 | PIK3CA | 0.99612132 |
| 55 | TGFBR2 | 0.99566767 |
| 56 | PIM2 | 0.98224013 |
| 57 | PRKCQ | 0.92210057 |
| 58 | CLK1 | 0.91387984 |
| 59 | CDK12 | 0.88024081 |
| 60 | MAP2K2 | 0.87788761 |
| 61 | MST1R | 0.87068982 |
| 62 | LCK | 0.84081466 |
| 63 | GRK5 | 0.83724634 |
| 64 | NEK9 | 0.83418783 |
| 65 | ALK | 0.81715706 |
| 66 | SMG1 | 0.76831999 |
| 67 | MAP3K5 | 0.75156764 |
| 68 | TAOK1 | 0.74800330 |
| 69 | SIK1 | 0.74311303 |
| 70 | MAPK7 | 0.74302166 |
| 71 | BMX | 0.73417739 |
| 72 | EPHA2 | 0.73169095 |
| 73 | TEC | 0.71000363 |
| 74 | CSK | 0.70948931 |
| 75 | MST4 | 0.70682300 |
| 76 | BCKDK | 0.69761263 |
| 77 | PRKD1 | 0.69351355 |
| 78 | CDK9 | 0.68769379 |
| 79 | TESK1 | 0.67843566 |
| 80 | FRK | 0.67035063 |
| 81 | MAP3K9 | 0.66586419 |
| 82 | TRIB3 | 0.63545668 |
| 83 | PDK1 | 0.62680533 |
| 84 | TAF1 | 0.59432317 |
| 85 | DAPK1 | 0.56587668 |
| 86 | MAP3K7 | 0.54774637 |
| 87 | PKN1 | 0.54407408 |
| 88 | MAPK4 | 0.52514759 |
| 89 | MAP3K3 | 0.52503019 |
| 90 | MAPK12 | 0.52376951 |
| 91 | FYN | 0.52191869 |
| 92 | JAK2 | 0.50855454 |
| 93 | GRK7 | 0.50569310 |
| 94 | FGFR2 | 0.49836270 |
| 95 | PRKD2 | 0.49449687 |
| 96 | MATK | 0.48336989 |
| 97 | CDK4 | 0.47573466 |
| 98 | CHUK | 0.46969495 |
| 99 | KSR2 | 0.46931744 |
| 100 | TGFBR1 | 0.44367434 |
| 101 | CDC42BPA | 0.42201686 |
| 102 | TTN | 0.42198613 |
| 103 | EPHB1 | 0.40329943 |
| 104 | PKN2 | 0.40152443 |
| 105 | MARK3 | 0.38219585 |
| 106 | NUAK1 | 0.37240402 |
| 107 | CDK6 | 0.36639897 |
| 108 | FGR | 0.36597590 |
| 109 | STK4 | 0.36549652 |
| 110 | PRKCD | 0.36532022 |
| 111 | SGK3 | 0.35831079 |
| 112 | ABL1 | 0.34852848 |
| 113 | MAPK11 | 0.34730592 |
| 114 | MAP3K8 | 0.34256616 |
| 115 | UHMK1 | 0.33985265 |
| 116 | WNK1 | 0.33912548 |
| 117 | FER | 0.33188369 |
| 118 | MAPKAPK3 | 0.32772681 |
| 119 | IGF1R | 0.31987087 |
| 120 | CCNB1 | 0.31300229 |
| 121 | TLK1 | 0.30180603 |
| 122 | MAP2K6 | 0.29500368 |
| 123 | BRD4 | 0.29388099 |
| 124 | INSR | 0.28276820 |
| 125 | PRKG2 | 0.27894085 |
| 126 | RPS6KB2 | 0.27738339 |
| 127 | MAPK3 | 0.27069610 |
| 128 | EGFR | 0.26197580 |
| 129 | RIPK1 | 0.25601785 |
| 130 | RPS6KA5 | 0.24631160 |
| 131 | RPS6KC1 | 0.24335306 |
| 132 | RPS6KL1 | 0.24335306 |
| 133 | LMTK2 | 0.23953873 |
| 134 | CDK7 | 0.22801057 |
| 135 | ADRBK2 | 0.22462474 |
| 136 | MAP3K4 | 0.22301465 |
| 137 | ZAP70 | 0.21381482 |
| 138 | NME1 | 0.21123386 |
| 139 | MAPKAPK2 | 0.21031969 |
| 140 | PRKAA1 | 0.20921659 |
| 141 | GSK3A | 0.19214220 |
| 142 | CSNK1A1L | 0.18800151 |
| 143 | CAMK1G | 0.18091446 |
| 144 | RPS6KA6 | 0.17677646 |
| 145 | DYRK1B | 0.17184551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 8.07492482 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.40192107 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.56483459 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.59196434 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.57228065 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.46148814 |
| 7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 3.09964647 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.97326791 |
| 9 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.79311922 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.90896702 |
| 11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.84015530 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.82809544 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.69769949 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.68718130 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66662276 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.59934330 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.57570553 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.56429855 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.45309627 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.43722415 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.37474447 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36130183 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.35915875 |
| 24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.35198043 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19261060 |
| 26 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.13807575 |
| 27 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.13153957 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11056709 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06393076 |
| 30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.04337027 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02647162 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98705213 |
| 33 | Measles_Homo sapiens_hsa05162 | 0.97569134 |
| 34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97395840 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 0.96976495 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95483885 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91411717 |
| 38 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89652044 |
| 39 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86981980 |
| 40 | DNA replication_Homo sapiens_hsa03030 | 0.86876096 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 0.86748631 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85058465 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 0.84550483 |
| 44 | Malaria_Homo sapiens_hsa05144 | 0.84239856 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83778994 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 0.81477722 |
| 47 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80764235 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78528027 |
| 49 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.74309021 |
| 50 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.73593509 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72511538 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.70387849 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69268764 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68134844 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67954433 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65476734 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.65392506 |
| 58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64941617 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.64615395 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64550475 |
| 61 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64278562 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.64074504 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63105139 |
| 64 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62980270 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62073730 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61513592 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60345716 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59497241 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.59018832 |
| 70 | Allograft rejection_Homo sapiens_hsa05330 | 0.58595721 |
| 71 | Ribosome_Homo sapiens_hsa03010 | 0.58529330 |
| 72 | Base excision repair_Homo sapiens_hsa03410 | 0.57263105 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57200423 |
| 74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56679207 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55917630 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.55477552 |
| 77 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.54556692 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52441700 |
| 79 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.52182683 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51623360 |
| 81 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.51423649 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51159612 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50819143 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48505338 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48096012 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46228872 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.45639860 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44609084 |
| 89 | Influenza A_Homo sapiens_hsa05164 | 0.43696657 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43681598 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43621519 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.42320007 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.41497206 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40399301 |
| 95 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.39510169 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39069098 |
| 97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.38782729 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38644107 |
| 99 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38566943 |
| 100 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.38425278 |
| 101 | Renin secretion_Homo sapiens_hsa04924 | 0.37806438 |
| 102 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.37313498 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36555266 |
| 104 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.35700601 |
| 105 | Legionellosis_Homo sapiens_hsa05134 | 0.35681832 |
| 106 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.34841397 |
| 107 | Alcoholism_Homo sapiens_hsa05034 | 0.33229137 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32392484 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29921979 |
| 110 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.28417544 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.27837618 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | 0.27762486 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27257641 |
| 114 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.25785994 |
| 115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.25400916 |
| 116 | Cocaine addiction_Homo sapiens_hsa05030 | 0.24555794 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.24390960 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23857063 |
| 119 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.23304923 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.21151452 |
| 121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.21080167 |
| 122 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.20831211 |
| 123 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.20729464 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19307699 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19091085 |
| 126 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.19060659 |
| 127 | Lysine degradation_Homo sapiens_hsa00310 | 0.18924744 |
| 128 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.18866801 |
| 129 | Purine metabolism_Homo sapiens_hsa00230 | 0.18736425 |
| 130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.18216052 |
| 131 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.17478967 |
| 132 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.17447255 |
| 133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.17223614 |
| 134 | Carbon metabolism_Homo sapiens_hsa01200 | 0.16735364 |
| 135 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16599935 |
| 136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16541442 |
| 137 | Lysosome_Homo sapiens_hsa04142 | 0.16439068 |
| 138 | Prostate cancer_Homo sapiens_hsa05215 | 0.14625899 |
| 139 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.14530438 |
| 140 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.12083449 |
| 141 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.11449073 |

